4 Major Epidural Catheter Companies in the World in 2020

The global Epidural Catheter industry is anticipated experience remarkable growth between 2022 and 2028, led by robust demand across key application segments. The product finds wide use across hospitals, clinics, and other key applications. The market for epidurals is also anticipated to develop as diabetes incidence rates rise. It is projected that the number of procedures performed will increase internationally.

An illustration of a plastic catheter is an epidural catheter (tube). This plastic tube is inserted into the epidural space of the human spine through the skin. It permits entry into the epidural area for the injection of painkillers like opioids or local anesthetics. For a predetermined amount of time, the temporary catheter is positioned on the left side. It is applied as a temporary remedy for painful ailments.

Business Research Insights forecasts the worldwide market for Epidural Catheter to hit USD 7.6 billion by 2028, growing at a CAGR of 4.6% during 2022-2028. Growing public health consciousness is anticipated to increase product demand.

Business Research Insights Presents the Top 4 Epidural Catheter Manufacturing Companies Globally

1.BD (U.S.)

The American multinational medical technology business Becton, Dickinson and Company, better known as BD, produces and markets reagents, instrument systems, and medical devices. In some regions, BD also offers consulting and analytics services. Based on its earnings for the fiscal year that ended on September 30, 2020, BD is ranked #177 on the Fortune 500 list for 2021. The business and CareFusion reached an agreement in October 2014 for a price of US$12.2 billion in cash and equity.

2. Smiths Medical, Inc. (U.S.)

With a focus on areas including critical care, safety equipment, and medication distribution, Smiths Medical is a maker of therapeutic, diagnostic, and surgical medical devices. The company's product lines include safety solutions, respiratory systems, tracheostomy products, temperature management systems, drainage systems, diabetes solutions, infusion devices, pain management products, interventional imaging systems, pressure monitoring devices, patient monitoring equipment, tracheostomy products, assisted reproductive technology, ventilation products, and vascular access devices.

The company operates throughout North America, Europe, and Asia Pacific through a network of distributors and branch offices. Smiths Medical's corporate office is located in St. Paul, Minnesota, in the United States.

3. Teleflex (U.S.)

Leading global provider of medical solutions for improving people's health and quality of life, Teleflex. All the Teleflex staff members agree that what we do every day counts. Leading global provider of medical solutions for improving people's health and quality of life, Teleflex.

In their wide-ranging portfolio, they offer solutions for vascular access, interventional cardiology, radiology, anaesthesia, emergency medicine, surgery, urology, and respiratory care. All of the Teleflex staff members agree that what we do every day counts. With more than 14,000 employees and its global headquarters in Wayne, Pennsylvania, Teleflex serves medical professionals in more than 150 countries.

4. B. Braun (Germany)

B. Braun is a German manufacturer of pharmaceutical and medical equipment with locations and production facilities in more than 60 nations, employing more than 63,000 people globally. The city of Melsungen in central Germany serves as its corporate headquarters. The company was founded in 1839, and the Braun family has owned it ever since.

95 percent of the more than 5.000 healthcare products that B. Braun sells are made in-house by the company. In 2018, the company's revenue was 6.908 billion euros.

COVID-19 Accelerated R&D Around Potential Benefits of Epidural Catheter

The COVID-19 virus outbreak had reached practically all of the world's nations. It has been deemed a public health emergency by the World Health Organization. Production activity and the supply chain were in decline on the market. Increasing demand for health education during the epidemic sped up market expansion. Patients with diabetes and respiratory conditions during the pandemic helped the product become more popular. Additionally, increased strategy implementation by important companies is anticipated to boost product demand.

Pharmaceutical and Nutritional Supplements will Continue to Generate Robust Demand

The continuous uptick in the occurrence of several chronic diseases and increasing healthcare R&D mean that the pharmaceutical sector will continue to present new opportunities for product suppliers. Meanwhile, nutritional supplements are experiencing significant demand across various consumer segments. Growing popularity of supplements will certainly propel the market for acetylcysteine over the next several years.